Randomized Study to Evaluate the Use of High-Dose Therapy as Part of Primary Treatment for “Aggressive” LymphomaUlrich Kaiser, K. Havemann, Irmgard Uebelacker et al.|Journal of Clinical Oncology|2002Cited by 139
Bendamustine Plus Rituximab Versus CHOP Plus Rituximab in the First-Line Treatment of Patients with Indolent and Mantle Cell Lymphomas - First Interim Results of a Randomized Phase III Study of the StiL (Study Group Indolent Lymphomas, Germany).Mathias Rummel, Ulrich von Gruenhagen, N. Niederle et al.|Blood|2007Cited by 65
Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohortsPeter Thuss‐Patience, Peter Reichardt, Dmitry Bichev et al.|British Journal of Cancer|2011Cited by 23
Docetaxel and capecitabine for advanced gastric cancer: Phase II study investigating dose dependent efficacy in two patient cohortsPeter Thuss‐Patience, Peter Reichardt, Albrecht Kretzschmar et al.|Journal of Clinical Oncology|2008Cited by 1